10-Q quarterly report · filed Oct 29, 2026

DaVita (DVA) Q3 2026 10-Q Quarterly Report

Short answer

DaVita (DVA) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $3.6B (up 4.6% year over year) with net income of $223M.

Q3 2026 key financials · XBRL

Revenue
$3.6B
+4.6% YoY · +0.7% QoQ
Net income
$223M
+48.3% YoY · −16.0% QoQ
Operating margin
14.0%
EPS (diluted)
$3.41
+66.3% YoY · −14.5% QoQ

Source: XBRL data from the DaVita (DVA) Q3 2026 10-Q on SEC EDGAR. USD.

DaVita Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Nine-month revenue $10.548B, up 5.2% YoY from $10.023B
  • U.S. dialysis revenue $9.004B, up 3.3% YoY, strongest segment
  • Operating income $1.560B, up 5.2% YoY from $1.483B, operating margin figures not provided
  • Operating cash flow $1.330B vs $1.346B YoY, share repurchases $870M for 5.837M shares
  • Headwinds: commercial mix pressure, rising labor and supply costs, policy uncertainty, China impairment charges of $62M

Risk Factors

  • No material changes to risk factors disclosed in the 2025 10-K
  • Carried-forward risk: forward-looking statements in quarterly Management’s Discussion and Analysis
  • Carried-forward risk: risks detailed in the 2025 10-K remain applicable

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other DaVita quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.